2026: Healthcare-Specific Private Equity Reporting Requirements Set To Go Into Effect

As 2025 wraps up, healthcare consolidation continues to face increased scrutiny at both the federal and state levels, which is reshaping how transactions move forward. Regulators aren’t necessarily blocking more deals, but they are requiring more disclosure, more documentation, and more justification, which is slowing timelines and making organizations more cautious about operational changes.

At the federal level, updated HSR filing requirements significantly increase the amount of information required for transactions, including narratives around cost, quality, and access to care, as well as disclosure of prior add-on acquisitions. Even smaller transactions from the past several years can now come under review, which adds complexity and friction to deal processes.

State-level oversight has also expanded, though unevenly. States like California, Oregon, Massachusetts, Washington, and Colorado are taking a more active role, particularly around CPOM, MSO governance, ownership transparency, and transaction reporting. This has made regulatory risk more dependent on geography, with certain states requiring far more careful structuring and review than others.

There has also been a shift in how private equity involvement is viewed. PE ownership alone is no longer the primary focus; instead, regulators are concentrating on market concentration, governance control, and influence over billing, coding, and operational decisions. Recent cases suggest a return to more traditional antitrust enforcement, with divestitures increasingly accepted as a remedy rather than outright deal blocks.

Noncompete agreements remain under scrutiny as well. While a nationwide ban did not move forward, enforcement activity has increased, particularly in healthcare, with regulators signaling continued focus on agreements that may restrict workforce mobility or competition.

Overall, the trend heading into 2026 points to a more complex regulatory environment where transactions still happen, but with longer timelines, higher compliance expectations, and greater emphasis on transparency, governance, and defensibility.

Source: https://www.hklaw.com/en/insights/publications/2025/12/charting-a-path-forward-in-2026-holland-knights-year-end-healthcare

Source: https://healthexec.com/topics/healthcare-management/healthcare-policy/2026-healthcare-specific-private-equity-reporting-requirements-set-go-effect?utm_source=newsletter&utm_medium=rb_news